Mutations in the VHL gene in sporadic apparently congenital polycythemia

Blood

Volumn 101, Issue 4, 2003, Pages 1591-1595

  Pastore, Yves D ^b   Jelinek, Jaroslav ^b   Ang, Sonny ^b   Guan, Yongli ^b   Liu, Enli ^b   Jedlickova, Katerina ^b   Krishnamurti, Lakshmanan ^b   Prchal, Josef T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; PROTEASOME; PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHILD; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; DNA TEMPLATE; ERYTHROID CELL; FEMALE; GENE MUTATION; GERM LINE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYDROXYLATION; HYPOXIA; MALE; POLYCYTHEMIA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0037441601     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1843     Document Type: Article

References (30)

1. Prchal JF, Prchal JT. Molecular basis for polycythemia. Curr Opin Hematol. 1999;6:100-109.
2. Prchal JT, Sokol L. "Benign erythrocytosis" and other familial and congenital polycythemias. Eur J Haematol. 1996;57:263-268.
3. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 2001;13:167-171.
4. 2 sensing. Science. 2001;292:464-468.
5. 2-regulated prolyl hydroxylation. Science. 2001;292:468-472.
6. Maxwell PH, Ratcliffe PJ. Oxygen sensors and angiogenesis. Semin Cell Dev Biol. 2002;13:29-37.
7. Friedrich CA, Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet. 2001;10:763-767.
8. Horton JC, Harsh GR 4th, Fisher JW, Hoyt WF. Von Hippel-Lindau disease and erythrocytosis: radioimmunoassay of erythropoietin in cyst fluid from a brainstem hemangioblastoma. Neurology. 1991;41:753-754.
9. Krieg M, Marti HH, Plate KH. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood. 1998;92:3388-3393.
10. Da Silva JL, Lacombe C, Bruneval P, et al. Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood. 1990;75:577-582.
11. Ang SO, Chen H, Gordeuk VR, et al. Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis. 2002;28:57-62.
12. Sergeyeva A, Gordeuk VR, Tokarev YN, Sokol L, Prchal JF, Prchal JT. Congenital polycythemia in Chuvashia. Blood. 1997;89:2148-2154.
13. Ang S, Chen H, Stockton D, Sergueeva A, Gordeuk VR, Prchal JT. Von Hippel-Lindau protein, Chuvash polycythemia and oxygen sensing [abstract]. Blood. 2001;98:748a.
14. Kralovics R, Sokol L, Broxson EH Jr, Prchal JT. The erythropoietin receptor gene is not linked with the polycythemia phenotype in a family with autosomal dominant primary polycythemia. Proc Assoc Am Physicians. 1997;109:580-585.
15. Stopka T, Zivny JH, Stopkova P, Prchal JF, Prchal JT. Human hematopoietic progenitors express erythropoietin. Blood. 1998;91:3766-3772.
16. Liu E, Guan Y, Pastore YD, Ang S, Prchal JT. Novel clonality assay of hematopoiesis by detection of transcriptional polymorphism of X chromosome genes BTK and FHL1 using SSCP analysis [abstract]. Blood. 2001;98:110a.
17. Erslev AJ. Erythropoietin titers in health and disease. Semin Hematol. 1991;28:2-7; discussion 7-8.
18. Prchal JT. Primary polycythemias. Curr Opin Hematol. 1995;2:146-152.
19. Gregg XT, Kralovics R, Prchal JT. A polymorphism of the X-linked gene IDS increases the number of females informative for transcriptional clonality assays. Am J Hematol. 2000;63:184-191.
20. Richard S, Croisille J, Yvart J, et al. Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy. Blood. 2002;99:3851-3853.
21. Kralovics R, Sokol L, Prchal JT. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. J Clin Invest. 1998;102:124-129.
22. Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin DJ, Prchal JT, Polyakova LA. High mortality due to thrombosis and cerebral hemorrhage in Chuvash polycythemia [abstract]. Blood. 2001;98:224a.
23. Olschwang S, Richard S, Boisson C, et al. Germline mutation profile of the VHL gene in von HippelLindau disease and in sporadic hemangioblastoma. Hum Mutat. 1998;12:424-430.
24. Wiesener MS, Seyfarth M, Warnecke C, et al. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von HippelLindau gene in a renal cell carcinoma. Blood. 2002;99:3562-3565.
25. Clifford SC, Cockman ME, Smallwood AC, et al. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet. 2001;10:1029-1038.
26. Ang SO, Chen H, Hirota K, et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet. 2002;32:614-621.
27. Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43-54.
28. Min J-H, Yang H, Ivan M, et al. Structure of an Hif-1αpVHL complex: hydroxyproline recognition in signaling. Science. 2002;296:1886-1889.
29. Hon W-C, Wilson M, Harlos K, et al. Structural basis for the recognition of hydroxyproline in Hif-1α by VHL. Nature. 2002;417:975-978.
30. Sato T, Maekawa T, Watanabe S, Tsuji K, Nakahata T. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. J Clin Invest. 2000;106:263-270.